Notice of Annual General Meeting 2020

Posted on May 6, 2020

Oslo, Norway 6 May 2020 – The Annual General Meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on 27 May 2020 at 10:00am (CEST). Due to the extraordinary situation with the Covid-19 pandemic, the Board has found it necessary to urge shareholders to exercise […]

First quarter 2020 results

Posted on May 6, 2020

Oslo (Norway), 6 May 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim first quarter 2020 results. Please find enclosed the report and presentation. Highlights in the quarter fimaChem *The main priorities during the COVID-19 pandemic has been identification and implementation of potential mitigating actions for the RELEASE study […]

PCI Biotech appoints Mr Ludovic Robin as Chief Business Officer

Posted on Apr 30, 2020

Oslo, Norway, 30 April 2020 – PCI Biotech announces the appointment of Mr Ludovic Robin, PharmD, MBA, as Chief Business Officer (CBO). Mr Robin will also serve as a member of PCI Biotech’s executive management team. He will lead all business and corporate development activities and be a key contributor to the strategic decision making […]